Join Prof. Rolland Gyulai as he presents his selection of Editor’s Picks from the June 2026 issue: First oral TNFR1 inhibitor for mild-to-moderate psoriasis Adjuvant treatment with immune checkpoint inhibitors - no benefit in acral melanomas Simple biomarkers predict favourable treatment response Mogamulizumab-associated rash – new insights into pathogenesis Read the Editor's Picks here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.70448 Rss Apple Podcaster →
